Fundraising FoxKelsie Biotech Chemicals R&D
Englewood, US · Founded 2019 · Delaware corporation · 2 known investors
Find your way into Kelsie Biotech Chemicals R&D
Sign up to see every warm intro you have to Kelsie Biotech Chemicals R&D
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kelsie Biotech Chemicals R&D team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
KelSie Biotech is a biotechnology company developing and commercializing drug-delivery technologies licensed from Sievers Biotech, including a Bubble Drying Process, sublingual wafers, and dry powder inhalable products. The company holds worldwide rights to formulate, sell, and sublicense finished products based on this technology and intellectual property.
Founders & leadership
Kelsie Biotech Chemicals R&D was founded in 2019 by Cameron F. Keluche.
Board
Investors · 2
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 2 rounds · 2019–2021
▶$1.3MraisedApr 2021 · 16 investors · Other TechnologyRule 506(b)
- Michael GruberDirector
- Jeffrey HowardDirector
- Ben KaantaExecutive Officer, Director
- Cameron F. KelucheExecutive Officer, Director
- Linda SonntagDirector
- Offering amount
- $2M
- Amount sold
- $1.3M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2MraisedJun 2019 · 5 investors · Other TechnologyRule 506(b)
- Christie SpencerExecutive Officer
- Cameron F. KelucheExecutive Officer, Director
- Jeffrey HowardDirector
- William J. GreenDirector
- Linda S. SonntagDirector
- Michael GruberDirector
- Offering amount
- $5M
- Amount sold
- $2M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Kelsie Biotech Chemicals R&D do?
- KelSie Biotech is a biotechnology company developing and commercializing drug-delivery technologies licensed from Sievers Biotech, including a Bubble Drying Process, sublingual wafers, and dry powder inhalable products. The company holds worldwide rights to formulate, sell, and sublicense finished products based on this technology and intellectual property.
- Who founded Kelsie Biotech Chemicals R&D?
- Kelsie Biotech Chemicals R&D was founded by Cameron F. Keluche in 2019.
- Who are Kelsie Biotech Chemicals R&D's investors?
- Kelsie Biotech Chemicals R&D's investors include 7thirty, Salveo Capital.
- How much funding has Kelsie Biotech Chemicals R&D raised?
- Kelsie Biotech Chemicals R&D has disclosed $3.3M raised across 2 rounds.
- Where is Kelsie Biotech Chemicals R&D headquartered?
- Kelsie Biotech Chemicals R&D is headquartered in Englewood, US.